drugset / Trial / NCT01116011

Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers

NCT01116011

Phase 1 Completed 30 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blind

Summary

This is a multiple ascending dose study (MAD) in the Japanese population with AZD7268. This MAD study will evaluate the safety, tolerability and pharmacokinetics of orally administered AZD7268 after multiple ascending doses.

Timeline

Start
2010-04
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7268 Small molecule Oral

Indications

No indication recorded.